Difficulty: Medium
Average Score: 82%
Practice
A 61-year-old female is hospitalized for COPD exacerbation. She is obese and not able to ambulate very far on her own. Upon discharge, the physician wants to send her home on heparin to reduce the risk of deep vein thrombosis. Why would the physician choose a low-molecular-weight heparin (LMWH) instead of unfractionated heparin (UFH)?
Correct answer
D
Rationale
In this scenario, the physician likely chose low-molecular-weight heparin (LMWH) over unfractionated heparin (UFH) for the patient due to the ease of management for outpatients. LMWH has several advantages over UFH in outpatient settings. LMWH has a more predictable anticoagulant response, allowing for fixed dosing without the need for frequent monitoring. This is especially beneficial for patients who may struggle with compliance or have limited access to healthcare services.
Option A is incorrect because LMWH and UFH have similar mechanisms of action as inhibitors of thrombin. Option B is incorrect as LMWH, like UFH, carries a risk of bleeding, though it may be lower. Option C is incorrect because LMWH can still cause heparin-induced thrombocytopenia (HIT), though the risk may be lower compared to UFH.
Educationally, this scenario highlights the importance of considering patient factors, such as ease of management and adherence, when selecting anticoagulant therapy. It also emphasizes the need for healthcare providers to weigh the benefits and risks of different anticoagulants based on individual patient characteristics and the specific clinical setting.
Option A is incorrect because LMWH and UFH have similar mechanisms of action as inhibitors of thrombin. Option B is incorrect as LMWH, like UFH, carries a risk of bleeding, though it may be lower. Option C is incorrect because LMWH can still cause heparin-induced thrombocytopenia (HIT), though the risk may be lower compared to UFH.
Educationally, this scenario highlights the importance of considering patient factors, such as ease of management and adherence, when selecting anticoagulant therapy. It also emphasizes the need for healthcare providers to weigh the benefits and risks of different anticoagulants based on individual patient characteristics and the specific clinical setting.